Abstract 2063P
Background
In this study we seek to learn more about the lifestyle habits of our cancer patients, with a particular emphasis in exercise and eating behaviours. We choose to focus on these two areas as they have an outsized impact on clinical outcomes such as mortality, risk of relapse, quality of life, sarcopenia, duration of hospitalizations, post-surgical complications, response to immunotherapy and even overall survival rates.
Methods
Observational study across a cross-section of cancer patients at the Medical Oncology Service of the Nuestra Señora de Candelaria University Hospital, Santa Cruz de Tenerife. The statistical significance of lifestyle habit changes is tested through a form and IPAQ, MUST, and SARC-F surveys using chi-squared tests.
Results
We involved 100 patients whose average age was 61 years. 46% of patients had lung cancer, 30% breast cancer and 10% gastrointestinal cancer. 59% patients had stage-four cancer, 48% were receiving first-line treatment and 54% were being treated with immunotherapy or target therapies. 99% of individuals considered their diet as an important pillar in their cancer disease. However, we found that only 47% had discussed aspects of their nutrition with their oncologist, but this was not statistically associated with a reduced risk of malnutrition. 80% considered that a healthy lifestyle could help reduce the adverse effects of the treatment. The validated test results showed that 45% had an intermediate-high risk of malnutrition according to the MUST test and 14% had risk of sarcopenia according to the SARC-F test. Patients receiving immunotherapy or target therapies had a higher risk of malnutrition than those receiving other treatments (50 vs 42%, p=.507). 47% were sedentary according to the IPAQ test and 80% who did not perform physical activity would start an adapted exercise program if it were available.
Conclusions
Our patients present good high-level awareness about the generally positive ways in which lifestyle changes involving healthier eating and exercise habits can impact the outcome of their treatments. However, we appreciate a need for more specific nutritional and fitness recommendations that patients can immediately put into practice, as well their ranked impact on their health.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2045P - Patient Reported Outcome Measures (PROMs) capturing therapy adherence of cancer patients: A systematic literature review
Presenter: Luise Richter
Session: Poster session 06
2046P - The importance of communicating bad news in medical education
Presenter: Georgios Goumas
Session: Poster session 06
2047P - Neutrop: A descriptive, observational study for G-CSF prescription in daily practice
Presenter: Florian Scotté
Session: Poster session 06
2048P - Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
Presenter: Lotte Hulskotte
Session: Poster session 06
2049P - Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
Presenter: Gisele Moreira
Session: Poster session 06
2050P - Integrating ayurveda herbs with standard of care for management of cancer or cancer treatment related anorexia
Presenter: Yogesh Bendale
Session: Poster session 06
2051P - E-PRO within comprehensive companion program for patients undergoing systemic cancer treatment to reduce emergency visits and inpatient admission in a Peruvian institution
Presenter: Patricia Rioja Viera
Session: Poster session 06
2052P - Adverse events in FLOT chemotherapy for locally advanced gastric cancer: An observational study of pre- and post-operative toxicity profiles
Presenter: Camila Oliveira
Session: Poster session 06
2053P - Dehospitalization through outpatient drug release in clinical pharmacy as a strategic cost-minimization action in a public oncology hospital in the Eastern Amazon: A quantitative analysis
Presenter: Kalysta Borges
Session: Poster session 06
2054P - Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Presenter: Colin Vercueil
Session: Poster session 06